Jasper M. Martens

Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial

Susanne G. H. Olthuis, F.A.V. Pirson, Florentina M.E. Pinckaers et al. · The Lancet · 2023 · 211 citations · Full text

Endovascular Technique, Cerebrovascular Disease, Thrombosis +17

Anesthetic management during endovascular treatment of acute ischemic stroke in the MR CLEAN Registry

Robert‐Jan B. Goldhoorn, Marie Louise E. Bernsen, Jeannette Hofmeijer et al. · Neurology · 2019 · 131 citations · Full text

Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial

Wouter van der Steen, Rob A. van de Graaf, Vicky Chalos et al. · The Lancet · 2022 · 125 citations · Full text

Thrombosis, Cardiovascular Disease, Endovascular Stroke Treatment +14

Long‐Term Follow‐up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug‐Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia

Marlon I. Spreen, Jasper M. Martens, Bob Knippenberg et al. · Journal of the American Heart Association · 2017 · 91 citations · Full text

Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial

Marlon I. Spreen, Jasper M. Martens, Bettina E. Hansen et al. · Circulation Cardiovascular Interventions · 2016 · 89 citations · Full text